MG-BL

MG-BL™ is a professional-grade Meso-Glide™ formulation designed to target hyperpigmentation, melasma, and uneven skin tone through controlled dermal delivery of pigment-regulating actives during microneedling treatments.

As part of the MG-COLLECTION™, it enables providers to address pigmentation concerns at a deeper level than traditional topical approaches.

Formulated with Kojic Acid, Vitamin C (Sodium Ascorbyl Phosphate), Liquorice Root, and Uva Ursi Extract, MG-BL™ helps regulate melanin production, improve skin clarity, and support a more uniform complexion while maintaining hydration through HylaFuse™ technology.

Pigmentation disorders are complex and influenced by:

• Melanin overproduction
• UV exposure and oxidative stress
• Hormonal changes (melasma)
• Post-inflammatory responses

Topical products alone often:

• Provide limited penetration
• Deliver inconsistent results
• Require long timelines for visible improvement

Effective pigmentation management requires:

• Targeted delivery of actives into the skin
• Regulation of melanin synthesis (tyrosinase inhibition)
• Ongoing control of oxidative stress
• Support for even skin regeneration

MG-BL™ is designed to address these pathways within a clinical treatment environment, improving both correction and prevention.

• Helps reduce the appearance of hyperpigmentation and melasma
• Supports brighter, more even skin tone
• Regulates melanin production at the source
• Improves clarity and skin radiance
• Helps reduce post-inflammatory pigmentation (PIH)
• Provides antioxidant protection against environmental stress
• Enhances treatment outcomes for pigmentation protocols
• Maintains hydration during treatment

• Hyperpigmentation and uneven skin tone
• Melasma and hormonally influenced pigmentation
• Sun damage and age spots
• Post-inflammatory hyperpigmentation (PIH)
• Pre- and post-procedure pigmentation management
• Dull or uneven complexion

MG-BL™ is used during microneedling as a targeted pigmentation infusion system.

Standalone Use
Applied directly during treatment, delivers pigment-regulating actives into the skin.

Blended Protocols
Combined 1:1 with MG-HA35™ or MG-HA35+™, enhances hydration and improves tolerance.

Protocol Role
Supports controlled melanin regulation, reduces risk of post-treatment pigmentation, improves consistency of clinical outcomes.

MG-BL™ is professional-use only.

Patients are transitioned to:

• BRITE LITE™
• ANTIOXIDANT COCKTAIL™
• SKIN VENEER™

to maintain results and support long-term pigmentation control.

Kojic Acid
Potent tyrosinase inhibitor, helps regulate melanin production, reduces appearance of dark spots and discoloration, less aggressive alternative to hydroquinone, provides antioxidant and antibacterial support.

Vitamin C (Sodium Ascorbyl Phosphate)
Stable, water-soluble Vitamin C derivative, neutralizes free radicals and oxidative stress, supports collagen production, helps brighten skin and regulate pigmentation pathways, enhances photoprotection and improves skin clarity.

Liquorice Root Extract
Anti-inflammatory and antioxidant, helps inhibit melanin production, reduces redness and irritation, supports more even skin tone.

Uva Ursi (Bearberry Extract)
Natural source of hydroquinone-like compounds, helps brighten and lighten pigmentation, provides antioxidant protection, supports reduction of dark spots and melasma.

Copper Peptides
Supports collagen production and skin repair, improves overall skin structure, helps enhance regeneration and recovery.

HylaFuse™ Hyaluronic Acid
Provides hydration during treatment, supports barrier function and comfort, enhances delivery of active ingredients.

Step 03 — TREAT (Pigmentation Regulation & Correction Phase)

MG-BL™ functions as a targeted correction system, ensuring:

• Controlled delivery of pigment-regulating actives
• Improved uniformity of treatment outcomes
• Reduced risk of post-inflammatory pigmentation

It is essential for structured pigmentation treatment protocols.